Global Bioenergies S.A. | Small-cap | Utilities
€0.03
7.01%
| Global Bioenergies Stock Comparison:
Global Bioenergies vs Engie S.AGlobal Bioenergies vs Methanor S.C.AGlobal Bioenergies vs Weyerhaeuser CompanyGlobal Bioenergies vs Electricité deGlobal Bioenergies vs Voltalia S.AGlobal Bioenergies vs CAC 40 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Income Metrics

Balance Sheet Metrics

Total Assets 9.7M
Total Liabilities 8.0M
Shareholders Equity 1.7M
Debt to Equity 4.70

Cash Flow Metrics

Revenue & Profitability Trend

Global Bioenergies Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i360.7K3.2M697.5K100.9K63.8K
Cost of Goods Sold i574.4K3.3M-1.1M680.7K-282.6K
Gross Profit i-213.7K-83.6K1.8M-579.8K346.5K
Gross Margin % i-59.3%-2.6%260.3%-574.4%542.6%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i196.0K281.1K413.8K1.4M151.4K
Other Operating Expenses i3.2M5.4M8.7M8.1M8.5M
Total Operating Expenses i3.4M5.7M9.1M9.6M8.6M
Operating Income i-6.1M-6.8M-11.6M-12.2M-13.0M
Operating Margin % i-1,689.5%-207.7%-1,662.9%-12,051.3%-20,404.9%
Non-Operating Items
Interest Income i1.7K81272021
Interest Expense i299.0K123.3K124.4K114.5K198.5K
Other Non-Operating Income-----
Pre-tax Income i-7.1M-9.8M-13.4M-13.5M-13.2M
Income Tax i-1.3M-1.2M-1.4M-1.7M-2.3M
Effective Tax Rate % i0.0%0.0%0.0%0.0%0.0%
Net Income i-5.9M-8.7M-12.0M-11.8M-10.9M
Net Margin % i-1,625.1%-266.4%-1,718.4%-11,664.0%-17,087.5%
Key Metrics
EBITDA i-3.5M-5.3M-11.1M-11.3M-9.6M
EPS (Basic) i-€-0.48€-0.80€-0.78€-1.08
EPS (Diluted) i-€-0.48€-0.80€-0.78€-1.08
Basic Shares Outstanding i-18149196149886061509949110291665
Diluted Shares Outstanding i-18149196149886061509949110291665

Income Statement Trend

Global Bioenergies Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i4.7M11.7M8.8M20.9M14.5M
Short-term Investments i170.5K170.5K173.1K146.6K360.2K
Accounts Receivable i13.1K19.5K79.5K16.7K19.6K
Inventory i401.9K568.8K2.6M2.0M2.0M
Other Current Assets----1.5K
Total Current Assets i8.7M15.0M15.5M26.9M21.9M
Non-Current Assets
Property, Plant & Equipment i13.7M-13.4M10.5M17.5M
Goodwill i69.2K565.8K1.0M1.5M1.9M
Intangible Assets i69.2K88.8K61.6K84.6K25.7K
Long-term Investments-----
Other Non-Current Assets1--1-1-1
Total Non-Current Assets i904.4K3.2M6.1M4.9M3.9M
Total Assets i9.7M18.3M21.6M31.8M25.8M
Liabilities
Current Liabilities
Accounts Payable i1.5M2.4M5.6M3.5M2.7M
Short-term Debt i3.9M1.5M1.4M2.2M7.9M
Current Portion of Long-term Debt-----
Other Current Liabilities--1.5M1.4M3.0M
Total Current Liabilities i6.0M3.0M7.4M7.9M16.2M
Non-Current Liabilities
Long-term Debt i1.8M4.8M6.4M5.1M151.1K
Deferred Tax Liabilities i0100-
Other Non-Current Liabilities-2-1-21.8M
Total Non-Current Liabilities i2.0M4.9M6.5M5.2M334.3K
Total Liabilities i8.0M7.8M13.9M13.1M16.6M
Equity
Common Stock i908.4K906.4K749.4K743.3K506.6K
Retained Earnings i-5.9M-8.7M-12.0M-16.5M-92.4M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i1.7M10.4M7.6M18.7M9.2M
Key Metrics
Total Debt i5.7M6.3M7.8M7.4M8.1M
Working Capital i2.8M12.1M8.0M19.0M5.7M

Balance Sheet Composition

Global Bioenergies Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-5.9M-8.7M-12.0M-11.8M-11.1M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i00000
Operating Cash Flow i-8.9M-8.7M-12.0M-11.8M-11.1M
Investing Activities
Capital Expenditures i-466.0K-325.4K-2.0M3.5K-
Acquisitions i-----
Investment Purchases i-----
Investment Sales i01.2M18.0K351.7K-
Investing Cash Flow i-466.0K887.5K-1.9M355.2K-
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i1.0M25.1K-1.1M4.9M
Debt Repayment i-213.4K-1.6M-970.5K-1.3M-1.2M
Financing Cash Flow i990.1K3.4M-125.4K21.2M9.6M
Free Cash Flow i-8.0M-8.2M-12.1M-14.7M-11.3M
Net Change in Cash i-8.3M-4.4M-14.1M9.8M-1.5M

Cash Flow Trend

Global Bioenergies Key Financial Ratios

Valuation Ratios

Price to Book 0.31
Price to Sales 1.53

Profitability Ratios

Profit Margin -59.26%
Operating Margin -17,560.98%
Return on Equity -96.88%
Return on Assets -30.21%

Financial Health

Current Ratio 1.43
Debt to Equity 334.06
Beta 1.48

Per Share Data

EPS (TTM) €-0.32
Book Value per Share €0.09
Revenue per Share €0.02

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
algbe529.2K-0.31-96.88%-59.26%334.06
Engie S.A 44.5B9.071.6315.72%6.84%137.52
Methanor S.C.A 6.7M17.670.51-5.39%100.00%0.00
Weyerhaeuser Company 386.2K---3,272.22%2.43%-
Electricité de 1.1B7.081.8827.51%10.60%1.89
Voltalia S.A 833.1M30.000.77-3.52%-7.96%211.68

Financial data is updated regularly. All figures are in the company's reporting currency.